These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34526431)

  • 21. Soluble LR11 competes with amyloid β in binding to cerebrospinal fluid-high-density lipoprotein.
    Yano K; Hirayama S; Misawa N; Furuta A; Ueno T; Motoi Y; Seino U; Ebinuma H; Ikeuchi T; Schneider WJ; Bujo H; Miida T
    Clin Chim Acta; 2019 Feb; 489():29-34. PubMed ID: 30448281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of CD40 ligand on CD4+ T-cells and platelets correlated to the coronary artery lesion and disease progress in Kawasaki disease.
    Wang CL; Wu YT; Liu CA; Lin MW; Lee CJ; Huang LT; Yang KD
    Pediatrics; 2003 Feb; 111(2):E140-7. PubMed ID: 12563087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Boolean analysis of the transcriptomic data to identify novel biomarkers of IVIG response.
    Rambabu N; Mathew MJ; Kaveri SV; Bayry J
    Autoimmun Rev; 2021 Jul; 20(7):102850. PubMed ID: 33971345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utility of ferritin as a predictor of the patients with Kawasaki disease refractory to intravenous immunoglobulin therapy.
    Yamamoto N; Sato K; Hoshina T; Kojiro M; Kusuhara K
    Mod Rheumatol; 2015; 25(6):898-902. PubMed ID: 25849851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Biomarker].
    Ogawa S
    Nihon Rinsho; 2014 Sep; 72(9):1578-84. PubMed ID: 25518405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating soluble LR11, a novel marker of smooth muscle cell proliferation, is enhanced after coronary stenting in response to vascular injury.
    Ogita M; Miyauchi K; Jiang M; Kasai T; Tsuboi S; Naito R; Konishi H; Dohi T; Yokoyama T; Okazaki S; Shimada K; Bujo H; Daida H
    Atherosclerosis; 2014 Nov; 237(1):374-8. PubMed ID: 25443876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.
    Wang Y; Wang W; Gong F; Fu S; Zhang Q; Hu J; Qi Y; Xie C; Zhang Y
    Arthritis Rheum; 2013 Mar; 65(3):805-14. PubMed ID: 23440694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kawasaki disease: a comprehensive review of treatment options.
    Patel RM; Shulman ST
    J Clin Pharm Ther; 2015 Dec; 40(6):620-5. PubMed ID: 26547265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Changes of P-selectin and E-selectin in children with Kawasaki disease].
    Qiu Y; Wu J; Fang XY; Lin Z; Wu BY; Cai RY; Xu XY; Zheng H
    Zhonghua Er Ke Za Zhi; 2004 Sep; 42(9):688-92. PubMed ID: 15482673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
    Yılmazer MM; Özdemir R; Meşe T; Küçük M; Öner T; Devrim İ; Bayram N; Güven B; Tavlı V
    Turk J Pediatr; 2019; 61(5):648-656. PubMed ID: 32104995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kawasaki disease in Sicily: clinical description and markers of disease severity.
    Maggio MC; Corsello G; Prinzi E; Cimaz R
    Ital J Pediatr; 2016 Nov; 42(1):92. PubMed ID: 27806720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammatory cytokine profiles during Cyclosporin treatment for immunoglobulin-resistant Kawasaki disease.
    Hamada H; Suzuki H; Abe J; Suzuki Y; Suenaga T; Takeuchi T; Yoshikawa N; Shibuta S; Miyawaki M; Oishi K; Yamaga H; Aoyagi N; Iwahashi S; Miyashita R; Honda T; Onouchi Y; Terai M; Hata A
    Cytokine; 2012 Dec; 60(3):681-5. PubMed ID: 22944461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum tenascin-C predicts resistance to steroid combination therapy in high-risk Kawasaki disease: a multicenter prospective cohort study.
    Yoshikane Y; Okuma Y; Miyamoto T; Hashimoto J; Fukazawa R; Kato T; Takeda A; Suda K; Matsushita T; Hiroe M; Imanaka-Yoshida K
    Pediatr Rheumatol Online J; 2021 Jun; 19(1):82. PubMed ID: 34090475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
    Xie T; Wang Y; Fu S; Wang W; Xie C; Zhang Y; Gong F
    Pediatr Rheumatol Online J; 2017 Mar; 15(1):17. PubMed ID: 28320400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of intravenous immunoglobulin resistance in patients with Kawasaki disease according to the duration of illness prior to treatment.
    Ha KS; Lee J; Lee KC
    Eur J Pediatr; 2020 Feb; 179(2):257-264. PubMed ID: 31713683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better?
    Li W; He X; Zhang L; Wang Z; Wang Y; Lin H; Yuan J; Xie X; Qin Y; Huang P
    Cardiovasc Ther; 2021; 2021():6660407. PubMed ID: 34239607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive value of C-reactive protein to albumin ratio as a biomarker for initial and repeated intravenous immunoglobulin resistance in a large cohort of Kawasaki disease patients: a prospective cohort study.
    Liu X; Wang L; Zhou K; Shao S; Hua Y; Wu M; Liu L; Wang C
    Pediatr Rheumatol Online J; 2021 Mar; 19(1):24. PubMed ID: 33712036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of serum IL6 and CRP levels with respect to coronary changes and treatment response in Kawasaki disease patients: a prospective study.
    Nandi A; Pal P; Basu S
    Rheumatol Int; 2019 Oct; 39(10):1797-1801. PubMed ID: 31302740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unique Molecular Patterns Uncovered in Kawasaki Disease Patients with Elevated Serum Gamma Glutamyl Transferase Levels: Implications for Intravenous Immunoglobulin Responsiveness.
    Wang Y; Li Z; Hu G; Hao S; Deng X; Huang M; Ren M; Jiang X; Kanegaye JT; Ha KS; Lee J; Li X; Jiang X; Yu Y; Tremoulet AH; Burns JC; Whitin JC; Shin AY; Sylvester KG; McElhinney DB; Cohen HJ; Ling XB;
    PLoS One; 2016; 11(12):e0167434. PubMed ID: 28002448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The elevated serum levels of calcineurin and nuclear factor of activated T-cells 1 in children with Kawasaki disease.
    Sun Y; Liu J; Geng Z; Tao Y; Zheng F; Wang Y; Fu S; Wang W; Xie C; Zhang Y; Gong F
    Pediatr Rheumatol Online J; 2020 Mar; 18(1):23. PubMed ID: 32183825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.